Almac to Demonstrate New Patient Management Services at the Euro DIA and Partnerships in Clinical Trials Conferences

SOUDERTON, Pennsylvania, March 23, 2011 - Almac announced today that its Clinical Technologies business unit, a
global leader in clinical trial management, will launch a suite of new
services designed to improve patient compliance and retention in clinical
trials. The new services will be demonstrated at the DIA's 23nd Annual
EuroMeeting located in Berlin, Germany, 27-28 March and at the Partnerships
in Clinical Trials Conference in Phoenix Arizona, 30 March 30 - 1 April .
Almac is a leading provider of IXRS(R) (Interactive Voice and Web Response)
services for patient and drug supply management. Recently, Almac has enhanced
its offerings by forming an exclusive integrated trial management alliance
with Exco InTouch, an innovative firm specializing in patient recruitment,
retention, compliance, and ePRO services.

The joint Almac-Exco InTouch service offering enhances patient retention
and compliance through the use of multiple technologies, such as SMS text
messages and emails. The technology reminds patients to complete key elements
of their required study obligations, such as taking medication, attending
appointments, fasting prior to laboratory testing, filling out diaries, and
others, while also collecting reasons for non-compliance. Almac is ideally
suited to deliver this new suite of services by combining its industry
leading IXRS(R) technology (used to screen, enroll, and randomize patients
into clinical trials) with the Exco InTouch patient reminder capabilities.
Working with sponsors on clinical trials, Almac will develop study-specific
patient retention and compliance programs that will begin immediately upon
randomization into the trial and remain in effect until the trial is
completed.

Almac Vice President of Business Development, Geri Beyer comments on the
launch: "We are very excited to offer the first-ever demo of this unique
integrated service line which will revolutionize the future of patient and
trial management for sponsors. With the increasing number and complexity of
trials that Almac is managing across the globe, we are pleased to offer
innovative and cost-effective technologies to our clients that will drive
compliance and enhance productivity throughout the clinical trial."

In addition to featuring its the new integration with Exco InTouch, Almac
will be demonstrating its world-class IXRS(R) (Interactive Voice and Web
Response) services and Almac's Interactive Reporting solution, two services
that were launched in 2010.

Visit Almac at the 23rd Annual DIA EuroMeeting (booth # 1501) and
Partnerships in Clinical Trials (booth #612) and participate in a special
poster presentation by Hannah O'Gorman on "Identifying Patients' Reasons for
Non-Compliance in ePRO Studies to Improve Data Collection Methods."

About Almac Group

The Almac Group provides a broad range of services from R&D, biomarker
discovery and development, API manufacture, formulation development, clinical
trial supply and IXRS(R) technology (IVRS/IWRS), to commercial-scale
manufacture. Almac provides services to more than 600 companies, including
all the world leaders in the pharmaceutical and biotech sectors.

The company employs over 3,000 individuals and is headquartered in
Craigavon, Northern Ireland. US operations are based in Pennsylvania, North
Carolina and California. Almac has now moved into its new North American
Headquarters located in Souderton PA.

Almac's Clinical Technologies business unit specializes in interactive
technology and service solutions to increase the quality and efficiency of
clinical trials. Our solutions include Interactive Voice and Web Response
Systems (IXRS(R)) for patient randomization and drug assignment, patient and
clinical supplies management, electronic-patient-reported-outcomes data
collection, and Web drug reconciliation. Almac's technologies have been
deployed in over 1600 clinical trials, incorporating over 1.5 million
patients in over 80 countries, and more than 60 languages.

For more information about the Almac Group, please visit
www.almacgroup.com or e-mail info@almacgroup.com

W: www.almacgroup.com

Contact: Kristi Bronico, T: +1-215-660-8500, E: clinicaltechnologies at almacgroup.com